Seeking Alpha

OPXA
  Opexa Therapeutics, Inc. - NASDAQ

9/17/2014, 12:31 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
OPXA vs. ETF Alternatives
Company Description
Opexa Therapeutics, Inc., Opexa Therapeutics, Inc., is engaged in developing personalized immunotherapy with the potential to treat illnesses, including multiple sclerosis. These therapies are based on the proprietary T-cell technology.
Sector: Healthcare
Industry: Biotechnology
Country: United States